Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.
about
The complotype: dictating risk for inflammation and infectionFamilial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases.A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.Affinity purification of human factor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variantComplement Factor H-Related Protein 3 Serum Levels Are Low Compared to Factor H and Mainly Determined by Gene Copy Number Variation in CFHR3Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.Complement Dysregulation and Disease: Insights from Contemporary Genetics.Annexin A2 Enhances Complement Activation by Inhibiting Factor HSequence and Expression of Complement Factor H Gene Cluster Variants and Their Roles in Age-Related Macular Degeneration Risk.Pregnant Woman with Atypical Hemolytic Uremic Syndrome Delivered a Healthy Newborn under Eculizumab Treatment.Neisseria meningitidis B vaccines: recent advances and possible immunization policies.Factor h: a complement regulator in health and disease, and a mediator of cellular interactions.Complement Biomarkers as Predictors of Disease Progression in Alzheimer's Disease.A novel, multiplexed targeted mass spectrometry assay for quantification of complement factor H (CFH) variants and CFH-related proteins 1-5 in human plasma.Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma.FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation.Complement in cancer: untangling an intricate relationship.Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4.
P2860
Q26862665-B206625A-8ABC-4DD3-9832-85207BC74C1EQ33404888-32AE7E93-0123-4317-B8C6-6114EFE74EB0Q33425911-81AF64C2-EA85-4C57-966F-598D78E6F817Q33426927-72CCA06C-2366-44F7-98FF-EB0054D2D0FAQ35053992-7CD0E48A-6112-49D9-87BE-E9E1FE4A3114Q35967438-08672A85-72BC-41C9-BA11-F3F299E5BDF7Q36182912-DF07E24F-6D61-4208-A7CD-AD2758319B00Q36221928-2DA90C91-2E92-47E9-BE6F-F92A984E9EFDQ36495141-7145ABF8-0A90-4719-AB95-988748AC2392Q36944530-3E0178DF-152C-4068-853E-69F2ED8A7D84Q37563002-B1DEF807-605D-448C-9D95-65AA652D2FCFQ38183156-00F85A5A-056D-4F7B-9746-39B8E9783A96Q38223669-6145E506-6E57-4235-8E4F-F67D7238DDD6Q39447009-3D6B5EAB-8942-4AC5-AB54-B6C75788ED6CQ40574092-FDA199FF-9830-442B-A42F-A2E711643C48Q47111288-274CAD18-93A5-45D1-8782-019FD59A5C5EQ48113964-4070D479-4B44-40CC-B9D3-4B9CDDF67FDAQ50049007-E77A2FA4-EE7F-49FE-AF53-4E659C3753A9Q51353137-557DBDE4-8A8F-4C16-A1EB-4CFD9CF4403AQ55261422-A41D1BC4-E9AD-4039-AF6C-3E53D8CB566A
P2860
Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@ast
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@en
type
label
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@ast
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@en
prefLabel
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@ast
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@en
P2093
P2860
P356
P1433
P1476
Variant-specific quantificatio ...... cal hemolytic uremic syndrome.
@en
P2093
Bryan P Morgan
Claire L Harris
Svetlana Hakobyan
P2860
P2888
P304
P356
10.1038/KI.2010.275
P407
P577
2010-08-11T00:00:00Z
P5875
P6179
1050553462